- Home
- TCMD vs OLMA Comparison
TCMD vs OLMA Comparison
Compare TCMD & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- OLMA
- Stock Information
- Founded
- TCMD 1995
- OLMA 2006
- Country
- TCMD United States
- OLMA United States
- Employees
- TCMD N/A
- OLMA N/A
- Industry
- TCMD Medical/Dental Instruments
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- TCMD Health Care
- OLMA Health Care
- Exchange
- TCMD Nasdaq
- OLMA Nasdaq
- Market Cap
- TCMD 362.7M
- OLMA 383.1M
- IPO Year
- TCMD 2016
- OLMA 2020
- Fundamental
- Price
- TCMD $15.05
- OLMA $4.99
- Analyst Decision
- TCMD Hold
- OLMA Strong Buy
- Analyst Count
- TCMD 2
- OLMA 4
- Target Price
- TCMD $18.00
- OLMA $28.33
- AVG Volume (30 Days)
- TCMD 353.1K
- OLMA 986.5K
- Earning Date
- TCMD 02-18-2025
- OLMA 03-10-2025
- Dividend Yield
- TCMD N/A
- OLMA N/A
- EPS Growth
- TCMD N/A
- OLMA N/A
- EPS
- TCMD 0.70
- OLMA N/A
- Revenue
- TCMD $292,984,000.00
- OLMA N/A
- Revenue This Year
- TCMD $8.83
- OLMA N/A
- Revenue Next Year
- TCMD $9.86
- OLMA N/A
- P/E Ratio
- TCMD $21.41
- OLMA N/A
- Revenue Growth
- TCMD 6.76
- OLMA N/A
- 52 Week Low
- TCMD $11.12
- OLMA $4.60
- 52 Week High
- TCMD $21.10
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- TCMD 29.47
- OLMA 38.98
- Support Level
- TCMD $14.60
- OLMA $4.94
- Resistance Level
- TCMD $18.06
- OLMA $5.34
- Average True Range (ATR)
- TCMD 0.64
- OLMA 0.42
- MACD
- TCMD -0.24
- OLMA -0.03
- Stochastic Oscillator
- TCMD 13.01
- OLMA 11.39
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.